MedPath

Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme

Not Applicable
Completed
Conditions
Hypertension
Interventions
Behavioral: Resistance training
Registration Number
NCT01963507
Lead Sponsor
Federal University of São Paulo
Brief Summary

The study aimed to evaluate the chronic effects of resistance training on blood pressure and biochemical exams in hypertensive elderlies and the influence of the polymorphism of the angiotensin converting enzyme in these response.

Detailed Description

To investigate the chronic effects of resistance training on blood pressure and biochemical exams in elderly, 135 hypertensive elderlies were divided into 2 groups: trained and control. The trained group was submitted to a resistance training period. Before the 16 weeks ACE gene was genotyped (PCR). Before and after 16 weeks, blood pressure (ambulatory), HDL-cholesterol, Total cholesterol, Glycemia, Triacylglycerol (colorimetric assay) and plasminogen activator inhibition (PAI-1), intercellular adhesion molecule (ICAM-1), vascular endothelial cell adhesion molecule (VCAM-1), Adiponectin, tumor necrosis factor alpha (TNF-alpha), C Reactive Protein, Angiotensin II, Angiotensin Converting Enzyme, Angiotensin 1-7, (ELISA assay) were measured.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
136
Inclusion Criteria
  • Hypertensives
  • Age 60 to 85 years
  • Nonactive
Exclusion Criteria
  • Orthopedic problems or other problem that prevented the exercises
  • Change in drug treatment during protocol
  • Absence in more than 25% of the exercise sessions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resistance trainingResistance trainingResistance training performed three times at week for 16 weeks, in 8 exercises for the main muscles, the protocol of 3 sets of 10 repetitions with intensity of 50% of 1 maximum repetition (MR).
Primary Outcome Measures
NameTimeMethod
Blood Pressure16 weeks

Blood pressure was measured by Ambulatorial Monitoring Blood Pressure before and after 16 weeks of intervention.

Secondary Outcome Measures
NameTimeMethod
Total Cholesterol16 weeks

Total cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.

Glycemia16 weeks

Glycemia was analyzed by colorimetric assay, before and after 16 weeks of intervention.

HDL-cholesterol16 weeks

HDL-cholesterol was analyzed by colorimetric assay, before and after 16 weeks of intervention.

Triacylglycerol16 weeks

Triacylglycerol was analyzed by colorimetric assay, before and after 16 weeks of intervention.

PAI-116 weeks

PAI-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.

ICAM-116 weeks

ICAM-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.

VCAM-116 weeks

VCAM-1 was analyzed by ELISA assay, before and after 16 weeks of intervention.

Adiponectin16 weeks

Adiponectin was analyzed by ELISA assay, before and after 16 weeks of intervention.

TNF alpha16 weeks

TNF alpha was analyzed by ELISA assay, before and after 16 weeks of intervention.

C Reactive Protein16 weeks

C Reactive Protein was analyzed by ELISA assay, before and after 16 weeks of intervention.

Angiotensin II16 weeks

Angiotensin II was analyzed by ELISA assay, before and after 16 weeks of intervention.

Angiotensin Converting Enzyme16 weeks

Angiotensin Converting Enzyme was analyzed by ELISA assay, before and after 16 weeks of intervention.

Angiotensin 1-716 weeks

Angiotensin 1-7 was analyzed by ELISA assay, before and after 16 weeks of intervention.

Trial Locations

Locations (1)

UNIMED

🇧🇷

Santos, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath